[{"headers": [["CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Millions", "3 Months Ended", "6 Months Ended"], ["Mar. 27, 2021", "Mar. 28, 2020", "Mar. 27, 2021", "Mar. 28, 2020"]], "sections": ["Operating expenses:", "Earnings per share:", "Shares used in computing earnings per share:"], "data": [["Net sales", "$ 89,584", "$ 58,313", "$ 201,023", "$ 150,132"], ["Cost of sales", "51,505", "35,943", "118,616", "92,545"], ["Gross margin", "38,079", "22,370", "82,407", "57,587"], ["Research and development", "5,262", "4,565", "10,425", "9,016"], ["Selling, general and administrative", "5,314", "4,952", "10,945", "10,149"], ["Total operating expenses", "10,576", "9,517", "21,370", "19,165"], ["Operating income", "27,503", "12,853", "61,037", "38,422"], ["Other income/(expense), net", "508", "282", "553", "631"], ["Income before provision for income taxes", "28,011", "13,135", "61,590", "39,053"], ["Provision for income taxes", "4,381", "1,886", "9,205", "5,568"], ["Net income", "$ 23,630", "$ 11,249", "$ 52,385", "$ 33,485"], ["Basic (in dollars per share)", "$ 1.41", "$ 0.64", "$ 3.11", "$ 1.91"], ["Diluted (in dollars per share)", "$ 1.40", "$ 0.64", "$ 3.08", "$ 1.89"], ["Basic (in shares)", "16,753,476", "17,440,402", "16,844,298", "17,550,281"], ["Diluted (in shares)", "16,929,157", "17,618,765", "17,021,423", "17,718,591"], ["Products", "", "", "", ""], ["Net sales", "$ 72,683", "$ 44,965", "$ 168,361", "$ 124,069"], ["Cost of sales", "46,447", "31,321", "108,577", "83,396"], ["Services", "", "", "", ""], ["Net sales", "16,901", "13,348", "32,662", "26,063"], ["Cost of sales", "$ 5,058", "$ 4,622", "$ 10,039", "$ 9,149"]]}, {"headers": [["CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions", "Mar. 27, 2021", "Sep. 26, 2020"]], "sections": ["Current assets:", "Non-current assets:", "Current liabilities:", "Non-current liabilities:", "Shareholders\u2019 equity:"], "data": [["Cash and cash equivalents", "$ 38,466", "$ 38,016"], ["Marketable securities", "31,368", "52,927"], ["Accounts receivable, net", "18,503", "16,120"], ["Inventories", "5,219", "4,061"], ["Vendor non-trade receivables", "14,533", "21,325"], ["Other current assets", "13,376", "11,264"], ["Total current assets", "121,465", "143,713"], ["Marketable securities", "134,539", "100,887"], ["Property, plant and equipment, net", "37,815", "36,766"], ["Other non-current assets", "43,339", "42,522"], ["Total non-current assets", "215,693", "180,175"], ["Total assets", "337,158", "323,888"], ["Accounts payable", "40,127", "42,296"], ["Other current liabilities", "45,660", "42,684"], ["Deferred revenue", "7,595", "6,643"], ["Commercial paper", "5,000", "4,996"], ["Term debt", "8,003", "8,773"], ["Total current liabilities", "106,385", "105,392"], ["Term debt", "108,642", "98,667"], ["Other non-current liabilities", "52,953", "54,490"], ["Total non-current liabilities", "161,595", "153,157"], ["Total liabilities", "267,980", "258,549"], ["Commitments and contingencies", "", ""], ["Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 16,686,305 and 16,976,763 shares issued and outstanding, respectively", "54,203", "50,779"], ["Retained earnings", "15,261", "14,966"], ["Accumulated other comprehensive income/(loss)", "(286)", "(406)"], ["Total shareholders\u2019 equity", "69,178", "65,339"], ["Total liabilities and shareholders\u2019 equity", "$ 337,158", "$ 323,888"]]}, {"headers": [["CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions", "Total", "Common stock and additional paid-in capital", "Retained earnings", "Retained earnings \nCumulative effect of change in accounting principle", "Accumulated other comprehensive income/(loss)", "Accumulated other comprehensive income/(loss) \nCumulative effect of change in accounting principle"]], "sections": ["Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]"], "data": [["Beginning balances at Sep. 28, 2019", "$ 90,488", "$ 45,174", "$ 45,898", "$ (136)", "$ (584)", "$ 136"], ["Common stock issued", "", "430", "", "", "", ""], ["Common stock withheld related to net share settlement of equity awards", "", "(1,052)", "(632)", "", "", ""], ["Share-based compensation", "", "3,480", "", "", "", ""], ["Net income", "33,485", "", "33,485", "", "", ""], ["Dividends and dividend equivalents declared", "", "", "(6,917)", "", "", ""], ["Common stock repurchased", "", "", "(38,516)", "", "", ""], ["Other comprehensive income/(loss)", "(2,341)", "", "", "", "(2,341)", ""], ["Ending balances at Mar. 28, 2020", "$ 78,425", "48,032", "33,182", "", "(2,789)", ""], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 0.385", "", "", "", "", ""], ["Beginning balances at Dec. 28, 2019", "$ 89,531", "45,972", "43,977", "0", "(418)", "0"], ["Common stock issued", "", "428", "", "", "", ""], ["Common stock withheld related to net share settlement of equity awards", "", "(101)", "(96)", "", "", ""], ["Share-based compensation", "", "1,733", "", "", "", ""], ["Net income", "11,249", "", "11,249", "", "", ""], ["Dividends and dividend equivalents declared", "", "", "(3,432)", "", "", ""], ["Common stock repurchased", "", "", "(18,516)", "", "", ""], ["Other comprehensive income/(loss)", "(2,371)", "", "", "", "(2,371)", ""], ["Ending balances at Mar. 28, 2020", "$ 78,425", "48,032", "33,182", "", "(2,789)", ""], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 0.1925", "", "", "", "", ""], ["Beginning balances at Sep. 26, 2020", "$ 65,339", "50,779", "14,966", "0", "(406)", "0"], ["Common stock issued", "", "561", "", "", "", ""], ["Common stock withheld related to net share settlement of equity awards", "", "(1,236)", "(2,047)", "", "", ""], ["Share-based compensation", "", "4,099", "", "", "", ""], ["Net income", "52,385", "", "52,385", "", "", ""], ["Dividends and dividend equivalents declared", "", "", "(7,042)", "", "", ""], ["Common stock repurchased", "(43,000)", "", "(43,001)", "", "", ""], ["Other comprehensive income/(loss)", "120", "", "", "", "120", ""], ["Ending balances at Mar. 27, 2021", "$ 69,178", "54,203", "15,261", "", "(286)", ""], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 0.41", "", "", "", "", ""], ["Beginning balances at Dec. 26, 2020", "$ 66,224", "51,744", "14,301", "$ 0", "179", "$ 0"], ["Common stock issued", "", "561", "", "", "", ""], ["Common stock withheld related to net share settlement of equity awards", "", "(135)", "(174)", "", "", ""], ["Share-based compensation", "", "2,033", "", "", "", ""], ["Net income", "23,630", "", "23,630", "", "", ""], ["Dividends and dividend equivalents declared", "", "", "(3,495)", "", "", ""], ["Common stock repurchased", "", "", "(19,001)", "", "", ""], ["Other comprehensive income/(loss)", "(465)", "", "", "", "(465)", ""], ["Ending balances at Mar. 27, 2021", "$ 69,178", "$ 54,203", "$ 15,261", "", "$ (286)", ""], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 0.205", "", "", "", "", ""]]}, {"headers": [["CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions", "6 Months Ended"], ["Mar. 27, 2021", "Mar. 28, 2020"]], "sections": ["Statement of Cash Flows [Abstract]", "Operating activities:", "Adjustments to reconcile net income to cash generated by operating activities:", "Changes in operating assets and liabilities:", "Investing activities:", "Financing activities:", "Supplemental cash flow disclosure:"], "data": [["Cash, cash equivalents and restricted cash, beginning balances", "$ 39,789", "$ 50,224"], ["Net income", "52,385", "33,485"], ["Depreciation and amortization", "5,463", "5,602"], ["Share-based compensation expense", "4,001", "3,407"], ["Deferred income tax benefit", "(207)", "(651)"], ["Other", "(474)", "(259)"], ["Accounts receivable, net", "(2,347)", "7,284"], ["Inventories", "(1,226)", "699"], ["Vendor non-trade receivables", "6,792", "7,923"], ["Other current and non-current assets", "(4,333)", "(8,866)"], ["Accounts payable", "(1,997)", "(13,520)"], ["Deferred revenue", "1,642", "1,223"], ["Other current and non-current liabilities", "3,045", "7,500"], ["Cash generated by operating activities", "62,744", "43,827"], ["Purchases of marketable securities", "(74,424)", "(66,489)"], ["Proceeds from maturities of marketable securities", "39,605", "39,738"], ["Proceeds from sales of marketable securities", "21,645", "27,762"], ["Payments for acquisition of property, plant and equipment", "(5,769)", "(3,960)"], ["Payments made in connection with business acquisitions, net", "(9)", "(1,134)"], ["Other", "0", "(572)"], ["Cash used in investing activities", "(18,952)", "(4,655)"], ["Proceeds from issuance of common stock", "561", "430"], ["Payments for taxes related to net share settlement of equity awards", "(3,160)", "(1,566)"], ["Payments for dividends and dividend equivalents", "(7,060)", "(6,914)"], ["Repurchases of common stock", "(43,323)", "(39,280)"], ["Proceeds from issuance of term debt, net", "13,923", "2,210"], ["Repayments of term debt", "(4,500)", "(5,250)"], ["Proceeds from commercial paper, net", "22", "1,518"], ["Proceeds from repurchase agreement", "0", "2,556"], ["Other", "(38)", "(51)"], ["Cash used in financing activities", "(43,575)", "(46,347)"], ["Increase/(Decrease) in cash, cash equivalents and restricted cash", "217", "(7,175)"], ["Cash, cash equivalents and restricted cash, ending balances", "40,006", "43,049"], ["Cash paid for income taxes, net", "10,276", "7,505"], ["Cash paid for interest", "$ 1,327", "$ 1,689"]]}]